0001209191-16-126850.txt : 20160609 0001209191-16-126850.hdr.sgml : 20160609 20160609163542 ACCESSION NUMBER: 0001209191-16-126850 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160608 FILED AS OF DATE: 20160609 DATE AS OF CHANGE: 20160609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Croarkin Richard CENTRAL INDEX KEY: 0001641815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 161706386 MAIL ADDRESS: STREET 1: C/O AERIE PHARMACEUTICALS, INC. STREET 2: 2030 MAIN STREET, SUITE 1500 CITY: IRVINE STATE: CA ZIP: 92614 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-08 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001641815 Croarkin Richard C/O AERIE PHARMACEUTICALS, INC. 2030 MAIN STREET, SUITE 1500 IRVINE CA 92614 1 0 0 0 Common Stock 2016-06-08 4 A 0 1700 0.00 A 1700 D Stock Option (right to buy) 19.50 2016-06-08 4 A 0 10000 0.00 A 2026-06-08 Common Stock 10000 10000 D Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 8, 2017. Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 8, 2016. /s/ Richard J. Rubino, Attorney-in-Fact for Richard Croarkin 2016-06-09